北京大学学报(医学版) ›› 2024, Vol. 56 ›› Issue (3): 519-525. doi: 10.19723/j.issn.1671-167X.2024.03.020

• 论著 • 上一篇    下一篇

乳酸对类风湿关节炎患者外周血CD4+T细胞亚群的调控作用

黄会娜1,赵静2,赵祥格1,白自然1,李霞1,王冠1,*()   

  1. 1. 大连医科大学基础医学院免疫学教研室, 辽宁大连 116044
    2. 北京大学人民医院风湿免疫科, 北京 100044
  • 收稿日期:2023-10-24 出版日期:2024-06-18 发布日期:2024-06-12
  • 通讯作者: 王冠 E-mail:guanwang1988@dmu.edu.cn
  • 基金资助:
    国家自然科学基金(82071834);国家自然科学基金(82271839);国家自然科学基金(82101896)

Regulatory effect of lactate on peripheral blood CD4+ T cell subsets in patients with rheumatoid arthritis

Huina HUANG1,Jing ZHAO2,Xiangge ZHAO1,Ziran BAI1,Xia LI1,Guan WANG1,*()   

  1. 1. Department of Immunology, College of Basic Medical Science, Dalian Medical University, Dalian 116044, Liaoning, China
    2. Department of Rheumatology and Immunology, Peking University People's Hospital, Beijing 100044, China
  • Received:2023-10-24 Online:2024-06-18 Published:2024-06-12
  • Contact: Guan WANG E-mail:guanwang1988@dmu.edu.cn
  • Supported by:
    the National Natural Science Foundation of China(82071834);the National Natural Science Foundation of China(82271839);the National Natural Science Foundation of China(82101896)

RICH HTML

  

摘要:

目的: 研究类风湿关节炎(rheumatoid arthritis, RA)患者血清乳酸水平及其与疾病活动度的关系,分析乳酸对RA患者外周血中CD4+T细胞的活化、分泌细胞因子能力以及对CD4+T细胞亚群的作用。方法: 选择大连医科大学附属第二医院风湿免疫科2019年10月至2021年9月连续收治的RA患者作为病例组,同期与RA患者性别年龄相匹配的大连医科大学附属第二医院体检中心健康人(healthy control, HC)作为对照组,收集两组外周血,乳酸检测试剂盒检测上清液中乳酸含量,并分析其与RA患者疾病评分的相关性。用乳酸刺激后,通过流式细胞术检测所有病例组RA患者外周血中CD4+T细胞的活化水平、CD4+T细胞亚群的比例以及CD4+T细胞分泌的细胞因子。结果: RA患者(n=66)的血清乳酸水平[(5.13±1.01) mmol/L vs. (1.72±0.91) mmol/L, P<0.001]明显高于HC(n=60),且与RA患者DAS28(disease activity score in 28 joints)-C反应蛋白(C-reactive protein,CRP)评分有相关性(r=0.273, P=0.029),乳酸浓度>5 mmol/L较浓度≤5 mmol/L的类风湿因子(rheumatoid factor, RF)[197.50 (26.03, 783.00) IU/mL vs. 29.30 (0.00, 102.60) IU/mL, P<0.01]和CRP [37.40 (11.30, 72.60) mg/L vs. 5.83 (2.36, 12.45) mg/L, P<0.001]的表达均升高,而红细胞沉降率(erythrocyte sedimentation rate, ESR)[42.00 (19.00, 77.00) mm/h vs. 25.00 (12.50, 45.50) mm/h, P>0.05]和抗环瓜氨酸多肽(cyclic citrullinated peptied, CCP)抗体[82.35 (17.70, 137.00) RU/mL vs. 68.60 (25.95, 119.70) RU/mL, P>0.05]的表达差异无统计学意义。与对照组HC相比,乳酸处理组的RA患者CD4+T细胞表面PD-1 (46.15%±8.54% vs. 41.67%±9.98%, P < 0.001)、诱导共刺激分子(inducible costimulatory molecule, ICOS)(25.77%±8.60% vs. 18.65%±7.94%, P < 0.01)和CD25 (25.89%±5.80% vs. 22.25%±4.59%, P < 0.01)的表达明显升高;乳酸处理组的RA患者CD4+T细胞中Th17 (4.62%±1.74% vs. 2.93%±1.92%, P < 0.05)、外周辅助性T (peripheral helper T, Tph)细胞(28.02%±6.28% vs. 20.32%±5.82%, P < 0.01)的比例升高;乳酸处理组的RA患者CD4+T细胞中IL-21(5.73%±1.59% vs. 4.75%±1.71%, P < 0.05)的表达上调。结论: RA患者血清乳酸水平升高,促进了RA患者CD4+T细胞活化和分泌IL-21,以及上调了RA患者Th17、Tph细胞的比例。

关键词: 类风湿关节炎, 乳酸, CD4+T细胞, 外周辅助性T细胞

Abstract:

Objective: To investigate the serum lactate level in patients with rheumatoid arthritis (RA) and its relationship with disease activity, and to analyze the effect of sodium lactate on the activation of CD4+ T cells, the ability of secreting cytokines and CD4+T cell subsets in peripheral blood of the RA patients. Methods: The peripheral blood of healthy controls (HC) and RA patients was collected, and the content of lactate in the supernatant was detected by lactate detection kit, the correlation between the content of lactate and the disease score of the RA patients was analyzed; the activation level of CD4+ T cells, the proportion of CD4+ T cell subsets and the cytokines secreted by CD4+ T cells in peripheral blood of all the RA patients were detected by flow cytometry after being stimulated with sodium lactate. Results: The serum lactate level in the RA patients (n=66) was significantly higher than that in the HC (n=60, P < 0.001), and there was a certain correlation with disease activity score in 28 joints (DAS28)-C-reactive protein (CRP) (r=0.273, P=0.029), The levels of rheumatoid factor [RF, 197.50 (26.03, 783.00) IU/mL vs. 29.30 (0.00, 102.60) IU/mL, P < 0.01], CRP [37.40 (11.30, 72.60) mg/L vs. 5.83 (2.36, 12.45) mg/L, P < 0.001], were increased in patients with the lactate concentration greater than 5 mmol/L were significantly higher than those in patients with the lactate concentration less than or equal 5 mmol/L, however, there was no significant difference in the expression of erythrocyte sedimentation rate [ESR, 42.00 (19.00, 77.00) mm/h vs. 25.00 (12.50, 45.50) mm/h, P>0.05] and anti-cyclic citrullinated peptied (CCP) antibody [82.35 (17.70, 137.00) RU/mL vs. 68.60 (25.95, 119.70) RU/mL, P>0.05]. Compared with the control group, the expression of PD-1 (46.15%±8.54% vs. 41.67%±9.98%, P < 0.001), inducible costimulatory molecule (ICOS, 5.77%±8.60% vs. 18.65%±7.94%, P < 0.01) and CD25 (25.89%±5.80% vs. 22.25%±4.59%, P < 0.01) on the surface of CD4+ T cells in the RA patients treated with sodium lactate was significantly increased. Compared with the control group, the proportion of Th17 (4.62%±1.74% vs. 2.93%±1.92%, P < 0.05) and Tph (28.02%±6.28% vs. 20.32%±5.82%, P < 0.01) cells in CD4+T cells of the RA patients in the sodium lactate treatment group increased. Compared with the control group, the expression of IL-21 (5.73%±1.59% vs. 4.75%±1.71%, P < 0.05) in CD4+T cells was up-regulated in the RA patients treated with sodium lactate. Conclusion: The level of serum lactate in RA patients is increased, which promotes the activation of CD4+T cells and the secretion of IL-21, and up-regulates the proportion of Th17 and Tph cells in the RA patients.

Key words: Rheumatoid arthritis, Lactate, CD4+T cell, Peripheral helper T (Tph) cell

中图分类号: 

  • R593.22

表1

RA患者和HC的基本特征"

Items RA patients (n=66) HC (n=60)
Age/years, M (P25, P75) 60.00 (50.75, 67.25) 55.00 (41.00, 57.00)
Gender, n(%)
   Male 14 (21.2) 16 (26.6)
   Female 52 (78.8) 44 (73.4)
Course of disease/months, M (P25, P75) 24.00 (8.00, 96.00), n=63
RF/(IU/mL), M (P25, P75) 79.80 (0.00, 544.00), n=65
anti-CCP/(RU/mL), M (P25, P75) 73.40 (22.80, 130.30), n=28
CRP/(mg/L), M (P25, P75) 14.40 (5.73, 49.65), n=64
ESR/(mm/h), M (P25, P75) 33.00 (16.00, 71.50), n=64
DAS28-CRP, M (P25, P75) 4.88 (3.92, 6.09), n=64

图1

HC和RA患者血清乳酸水平检测及与疾病活动度相关性分析"

图2

乳酸对RA患者CD4+T细胞活性的影响"

图3

乳酸对RA患者CD4+T细胞亚群的影响"

图4

乳酸对RA患者CD4+T细胞分泌细胞因子能力的影响"

1 Ding Q , Hu W , Wang R , et al. Signaling pathways in rheumatoid arthritis: Implications for targeted therapy[J]. Signal Transduct Target Ther, 2023, 8 (1): 68.
doi: 10.1038/s41392-023-01331-9
2 McInnes IB , Schett G . The pathogenesis of rheumatoid arthritis[J]. N Engl J Med, 2011, 365 (23): 2205- 2219.
doi: 10.1056/NEJMra1004965
3 Chen W , Yu Y , Zheng SG , et al. Human gingival tissue-derived mesenchymal stem cells inhibit proliferation and invasion of rheumatoid fibroblast-like synoviocytes via the CD39/CD73 signaling pathway[J]. Rheumatol Autoimmun, 2023, 3, 90- 99.
doi: 10.1002/rai2.12075
4 Wang D , Li Y , Liu Y , Shi G . The role of autoreactive T cell in the pathogenesis of rheumatoid arthritis and implications for T cell targeted vaccine therapy[J]. Minerva Med, 2015, 106 (3): 157- 167.
5 Yamada H . The search for the pathogenic T cells in the joint of rheumatoid arthritis: Which T-cell subset drives autoimmune inflammation[J]. Int J Mol Sci, 2023, 24 (8): 6930.
doi: 10.3390/ijms24086930
6 Chemin K , Gerstner C , Malmström V . Effector functions of CD4+ T cells at the site of local autoimmune inflammation: Lessons from rheumatoid arthritis[J]. Front Immunol, 2019, 10, 353.
doi: 10.3389/fimmu.2019.00353
7 Yoshitomi H . Peripheral helper T cell responses in human diseases[J]. Front Immunol, 2022, 13, 946786.
doi: 10.3389/fimmu.2022.946786
8 Lucas C , Perdriger A , Amé P . Definition of B cell helper T cells in rheumatoid arthritis and their behavior during treatment[J]. Semin Arthritis Rheum, 2020, 50 (5): 867- 872.
doi: 10.1016/j.semarthrit.2020.06.021
9 Huang Y , Ba X , Han L , et al. T peripheral helper cells in autoimmune diseases: What do we know[J]. Front Immunol, 2023, 14, 1145573.
doi: 10.3389/fimmu.2023.1145573
10 Sun S , Li H , Chen J , et al. Lactic acid: No longer an inert and end-product of glycolysis[J]. Physiology (Bethesda), 2017, 32 (6): 453- 463.
11 Ye L , Jiang Y , Zhang M . Crosstalk between glucose metabolism, lactate production and immune response modulation[J]. Cytokine Growth Factor Rev, 2022, 68, 81- 92.
doi: 10.1016/j.cytogfr.2022.11.001
12 段姣妞, 张改连. 乳酸在类风湿关节炎发病机制及治疗中的研究进展[J]. 中华风湿病学杂志, 2022, 26 (12): 842- 845.
doi: 10.3760/cma.j.cn141217-20220323-00104
13 Haas R , Smith J , Rocher-Ros V , et al. Lactate regulates metabolic and pro-inflammatory circuits in control of T cell migration and effector functions[J]. PLoS Biol, 2015, 13 (7): e1002202.
doi: 10.1371/journal.pbio.1002202
14 Pucino V , Certo M , Bulusu V , et al. Lactate buildup at the site of chronic inflammation promotes disease by inducing CD4(+) T cell metabolic rewiring[J]. Cell Metab, 2019, 30 (6): 1055- 1074. e8.
doi: 10.1016/j.cmet.2019.10.004
15 Pucino V , Bombardieri M , Pitzalis C , et al. Lactate at the crossroads of metabolism, inflammation, and autoimmunity[J]. Eur J Immunol, 2017, 47 (1): 14- 21.
doi: 10.1002/eji.201646477
16 Chang X , Wei C . Glycolysis and rheumatoid arthritis[J]. Int J Rheum Dis, 2011, 14 (3): 217- 222.
doi: 10.1111/j.1756-185X.2011.01598.x
17 Wang Q , Asenso J , Xiao N , et al. Lactic acid regulation: A potential therapeutic option in rheumatoid arthritis[J]. J Immunol Res, 2022, 2022, 2280973.
18 Rao DA , Gurish MF , Marshall JL , et al. Pathologically expanded peripheral T helper cell subset drives B cells in rheumatoid arthritis[J]. Nature, 2017, 542 (7639): 110- 114.
doi: 10.1038/nature20810
19 Marks KE , Rao DA . T peripheral helper cells in autoimmune diseases[J]. Immunol Rev, 2022, 307 (1): 191- 202.
doi: 10.1111/imr.13069
[1] 刘东武, 陈杰, 高明利, 于静. 类风湿关节炎伴发淋巴结Castleman样病理改变1例[J]. 北京大学学报(医学版), 2024, 56(5): 928-931.
[2] 汤晓菲,李永红,丁秋玲,孙卓,张阳,王育梅,田美伊,刘坚. 类风湿关节炎患者下肢深静脉血栓发病率及危险因素[J]. 北京大学学报(医学版), 2024, 56(2): 279-283.
[3] 邹雪,白小娟,张丽卿. 艾拉莫德联合托法替布治疗难治性中重度类风湿关节炎的疗效[J]. 北京大学学报(医学版), 2023, 55(6): 1013-1021.
[4] 吴琦,蔡月明,何娟,黄文蒂,王庆文. 血脂异常与类风湿关节炎肺间质病变的相关性分析[J]. 北京大学学报(医学版), 2023, 55(6): 982-992.
[5] 张警丰,金银姬,魏慧,姚中强,赵金霞. 体重指数与类风湿关节炎临床特征的相关性分析[J]. 北京大学学报(医学版), 2023, 55(6): 993-999.
[6] 金银姬,孙琳,赵金霞,刘湘源. 血清IgA型抗鼠科肉瘤病毒癌基因同源物B1抗体在类风湿关节炎中的意义[J]. 北京大学学报(医学版), 2023, 55(4): 631-635.
[7] 蔡文心,李仕成,刘一鸣,梁如玉,李静,郭建萍,胡凡磊,孙晓麟,李春,刘栩,叶华,邓立宗,李茹,栗占国. 类风湿关节炎临床分层及其特征的横断面研究[J]. 北京大学学报(医学版), 2022, 54(6): 1068-1073.
[8] 程昉,杨邵英,房星星,王璇,赵福涛. CCL28-CCR10通路在类风湿关节炎单核细胞迁移中的作用[J]. 北京大学学报(医学版), 2022, 54(6): 1074-1078.
[9] 刘蕊,赵金霞,闫良. 类风湿关节炎合并下肢静脉血栓患者的临床特点[J]. 北京大学学报(医学版), 2022, 54(6): 1079-1085.
[10] 张警丰,金银姬,魏慧,姚中强,赵金霞. 类风湿关节炎患者生活质量与疾病活动度的横断面研究[J]. 北京大学学报(医学版), 2022, 54(6): 1086-1093.
[11] 高超,陈立红,王莉,姚鸿,黄晓玮,贾语博,刘田. 类风湿关节炎合并纤维肌痛简易分类标准的临床验证[J]. 北京大学学报(医学版), 2022, 54(2): 278-282.
[12] 娄雪,廖莉,李兴珺,王楠,刘爽,崔若玫,徐健. 类风湿关节炎患者外周血TWEAK基因启动子区甲基化状态及其表达[J]. 北京大学学报(医学版), 2021, 53(6): 1020-1025.
[13] 钟华,徐丽玲,白明欣,苏茵. 类风湿关节炎患者趋化因子CXCL9和CXCL10在骨侵蚀中的作用[J]. 北京大学学报(医学版), 2021, 53(6): 1026-1031.
[14] 罗靓,霍文岗,张钦,李春. 类风湿关节炎合并角膜溃疡的临床特点和相关因素分析[J]. 北京大学学报(医学版), 2021, 53(6): 1032-1036.
[15] 张璐,胡小红,陈澄,蔡月明,王庆文,赵金霞. 类风湿关节炎初治患者颈椎失稳情况及临床特征[J]. 北京大学学报(医学版), 2021, 53(6): 1049-1054.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
No Suggested Reading articles found!